![[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!](https://businessfortnight.com/wp-content/uploads/2025/10/Toyota-Times-Century-as-a-Brand-Lexus-as-Innovation-All-218x150.jpg "[Toyota Times] Century as a Brand, Lexus as Innovation: All the Details on Toyota's New Project!")
MORRISVILLE, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq: SYNH), the one totally built-in biopharmaceutical options group, at this time introduced the appointment of William E. Klitgaard to its Board of Directors. Mr. Klitgaard was beforehand a member of the Syneos Board from 2017 till May 2022, having resigned as a result of a private matter. The Company additionally introduced at this time that Todd M. Abbrecht is stepping down from its Board of Directors.
“We are excited to welcome Bill back to the Syneos Health Board,” stated John Dineen, Chair of the Syneos Health Board of Directors. “Bill’s deep financial expertise combined with his knowledge of our company are a welcome addition to an already strong Board, enhancing its composition. This appointment will support continued successful oversight of our strategy as we speed our customers’ delivery of important therapies to patients.”
Mr. Dineen added, “Syneos Health has been well served by Todd’s contributions, and we thank him for his years of service to the Company.”
Mr. Klitgaard will function a Class II director and as a member of the Company’s Audit Committee. With these modifications, the Syneos Health Board stays comprised of 10 administrators, 9 of whom are impartial.
William E. Klitgaard
Mr. Klitgaard presently serves on the board of administrators of XIFIN, Inc., a well being info expertise firm and Avista Public Acquisition Corp. II, a particular objective acquisition firm, the place he serves because the Chair of the Audit Committee.
Mr. Klitgaard was an Operating Executive at Avista Capital Partners, a non-public fairness agency targeted on healthcare from 2020 to 2021. He beforehand served because the President of Enlighten Health, a division of LabCorp from 2015 to 2016. He additionally held numerous roles over his 19-year profession at Covance, together with three years as Corporate Senior Vice President and Chief Information Officer, and practically twelve years as Corporate Senior Vice President and Chief Financial Officer. He acquired his Bachelor of Arts in Economics from the University of California at Berkeley, and his Masters of Science from the Sloan Management School on the Massachusetts Institute of Technology.
About Syneos Health
Syneos Health® (Nasdaq:SYNH) is the one totally built-in biopharmaceutical options group purpose-built to speed up buyer success. We lead with a product improvement mindset, strategically integrating medical improvement, medical affairs and business capabilities to deal with trendy market realities.
We carry collectively greater than 29,000 minds, throughout greater than 110 international locations, with a deep understanding of affected person and doctor behaviors and market dynamics. Together we share insights, use the newest applied sciences and apply superior business practices to hurry our prospects’ supply of essential therapies to sufferers.
Syneos Health helps a various, equitable and inclusive tradition that cares for colleagues, prospects, sufferers, communities and the setting.
To study extra about how we’re Shortening the gap from lab to life®, go to syneoshealth.com or subscribe to our podcast.
